A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma.
about
Botulinum Toxin Off-Label Use in Dermatology: A Review.Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review.The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014.Optimal management of digital ulcers in systemic sclerosisDiagnosis and Management of Systemic Sclerosis: A Practical Approach.Therapeutic implications from the pathogenesis of Raynaud's phenomenon.Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.Non-healing ischaemic digital ulcer in a systemic sclerosis patient: a challenging clinical case.Evidence-based management of Raynaud's phenomenon.
P2860
Q33781874-5C305DC1-7994-4D9D-A872-2E5B50AB665AQ36091433-1C1E19CE-CBBA-42AA-81EC-13E5847B4245Q36352392-F77EFD75-7BD1-4B57-885A-C767AF463E15Q38379767-227BD124-1CC9-4383-BB99-A5410E1A5151Q38537531-BC14C21E-3F97-434F-83AC-C8ED843DAB7EQ38667111-3F9E9DAB-7662-4180-A555-3D9E6CA1B57AQ39090456-ECF906DF-F5E1-40BC-8A33-205E752E6A06Q40296383-4462B2F8-09E5-402F-9124-4281DEF7C77FQ40453036-3E9FC4ED-A914-47EB-B0EF-A776292497A6Q47803000-39F60921-722F-4BC6-A1A3-083A793A91B9
P2860
A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A prospective study of the use ...... e associated with scleroderma.
@en
type
label
A prospective study of the use ...... e associated with scleroderma.
@en
prefLabel
A prospective study of the use ...... e associated with scleroderma.
@en
P2860
P356
P1476
A prospective study of the use ...... e associated with scleroderma.
@en
P2093
P2860
P304
P356
10.1177/1753193413516242
P577
2013-12-24T00:00:00Z